FDA Has Granted Request for End of Phase 2 Meeting to Discuss Alcohol Use Disorder Treatment, AD04 Homeschizophrenia May 8, 2025 byhealth0
FDA Filing Fee Waiver for New Drug Application of NRX-100 for Suicidal Depression Homeschizophrenia May 8, 2025 byhealth0
